Ruthven N A H Lewis

Title: Ruthven N A H Lewis: Innovator in Antimicrobial Peptide Compositions

Introduction

Ruthven N A H Lewis is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of antimicrobial research, particularly through his innovative work on peptide compositions. His dedication to advancing medical science is evident in his patented inventions.

Latest Patents

Ruthven holds a patent for "Antimicrobial peptide compositions and method." This invention focuses on antimicrobial cyclic peptides and peptide analogs that exhibit relatively low hemolytic activity. The peptides developed by Ruthven are effective in killing and inhibiting the growth of various microorganisms, including gram-positive bacteria, gram-negative bacteria, fungi, and mycoplasma. The patent also discloses methods for inhibiting or killing these microorganisms, along with therapeutic preparations for such purposes.

Career Highlights

Ruthven is associated with Pence, Inc., where he continues to work on innovative solutions in the field of antimicrobial research. His expertise and contributions have positioned him as a valuable asset in the scientific community.

Collaborations

Ruthven has collaborated with notable colleagues, including Leslie H Kondejewski and Robert S Hodges. These partnerships have further enhanced the impact of his research and innovations.

Conclusion

Ruthven N A H Lewis is a distinguished inventor whose work on antimicrobial peptide compositions has the potential to significantly influence medical treatments. His contributions to science and collaboration with other experts highlight his commitment to innovation in healthcare.